Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
NEW YORK, March 25, 2016 -- Rosen Law Firm, a global investor rights law firm, reminds investors of Third Avenue Focused Credit Institutional Fund (NASDAQ:TFCIX) and Third Avenue Focused Credit Investor Fund (NASDAQ:TFCVX) (collectively, “Third Avenue”) from March 1, 2013 through December 10, 2015, all dates inclusive (the “Class Period”) of the important March 29, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Third Avenue investors under the federal securities laws.
To join the Third Avenue class action, go to the firm’s website at http://rosenlegal.com/cases-803.html or call Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
The Complaint alleges that Defendants failed to disclose that Third Avenue consistently held more than 15% of its net assets in illiquid securities even though Third Avenue’s Registration Statements and Prospectuses stated that Third Avenue maintained only a small proportion of its investments in illiquid securities and at no point held more than the 15% threshold set by the SEC. When declining asset prices and customer redemptions caused Third Avenue to suspend customer redemptions and place the fund’s assets in a liquidating trust, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 29, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://rosenlegal.com/cases-803.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com
